nicotine
AssetSmall moleculeAlso A643, Nicotine Patch
Nicotinic acetylcholine receptor agonist
- Stage
- Approved
- Modality
- Small molecule
- Target
- CHRNA4
- Indications
- 5
- Trials
- 198
- Developers
- 3
Indications
5Smoking
Approvedaccessdata.fda.gov7 Oct 2026
Smoking cessation
Approvedaccessdata.fda.gov7 Oct 2026
Tobacco dependence
Phase 3COMPLETEDNCT00749463clinicaltrials.gov7 Oct 2026
2 more
- Targets and what it contains3
- Owner and partners3
- Trials198
- Evidence for its targets3
- Competitors5
- Signals15
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 21 sources